ELI LILLY & Co is 74.3x more valuable than Jazz Pharmaceuticals plc by market capitalization ($1.070 T vs $14.41 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JAZZ | LLY |
|---|---|---|
| Market cap | $14.41 B | $1.070 T |
| US-listed rank | #749 | #10 |
| Revenue (latest FY) | $4.27B | $65.18B |
| Net income (latest FY) | -$356.15M | $20.64B |
| Net margin | -8.3% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 2,093 | 989 |
ELI LILLY & Co is 74.3x more valuable than Jazz Pharmaceuticals plc by market capitalization ($1.070 T vs $14.41 B).
In their latest fiscal years, Jazz Pharmaceuticals plc reported $4.27B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Jazz Pharmaceuticals plc and ELI LILLY & Co, or browse the full rankings.